Dr Yi-Xiang Wang, MD
Dr. Yi-Xiang Wang read medicine and trained in diagnostic and interventional radiology in China. He did post-doctoral fellowships in Sheffield Medical School, UK, and Rotterdam School of Medicine (Erasmus), The Netherlands. Prior to his current post, Dr. Wang was with AstraZeneca Pharmaceuticals R & D (UK) as a senior scientist and associate team leader. He joined the Faculty of Medicine at the Chinese University of Hong Kong in late 2006, where he is currently a substantiated associate professor. In principle investigator or co-principle investigator capacity, he discovered magnetic resonance T1rho relaxation time is increased in fibrotic liver, and established the normal magnetic resonance T1rho relaxation time in healthy livers. He found the spine osteoporotic fracture rate (prevalence) in elderly people is the same in Chinese, Korean, Japanese, and Latin American. He discovered in elderly subjects intervertebral disc degeneration is more common and more severe in women than men, and estrogen is beneficial for intervertebral disc. He established the prevalence and progression rate of spondylolisthesis in elderly Chinese men and women. He also discovered the regression pattern of chronic radiation induced brain injury. He pioneered Chemical Exchange Saturation Transfer magnetic resonance technique in liver application. He is the founding editor of the journal Quantitative Imaging in Medicine and Surgery. Dr. Wang received a number of international awards, and delivered a number of international invited lectures. Dr. Wang published over 200 papers in international journals, and his work has been cited over 6,500 times according to ISI web of science. He is a regular reviewer of a number of European and North American research funding agencies.